Extended-Spectrum Beta-Lactamases (ESBLs) are enzymes that can be produced by bacteria making them resistant to cephalosporins e.g. cefuroxime, cefotaxime and ceftazidime - which are the most widely used antibiotics in many hospitals
ESBLs were first described in the mid-1980s and during the 1990s were mostly found in Klebsiella species, mostly in hospitals and often in intensive care units treating the most vulnerable patients
a newer class of ESBL (called CTX-M enzymes) has emerged and these have been widely detected among Escherichia coli ( E. coli) bacteria
these ESBL-producing E. coli are able to resist penicillins and cephalosporins and are found most often in urinary tract infections - though not simple cystitis
have been found in the community as well as in hospitals, but patients with 'community acquired' infections may have had previous contact with hospitals
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.